Vir Das announces found-footage horror film ‘Baara Number’, to begin shoot in June. Bollywood News: Latest Bollywood News, ...

Vir has a promising pipeline, and expects to report data this year on several phase 2 clinical trials. Vir's revenue rose by 133.4% last year. The Food and Drug Administration recently made a decision ...

Vir Das will be co-directing the film with Kavi Shastri, with whom he also collaborated on ‘Happy Patel: Khatarnak Jasoos’ ...

Vir signed a “landmark” collaboration with Astellas to advance VIR-5500, receiving $315 million upfront ( $240M cash + $75M equity) and becoming eligible for up to $1.37 billion in milestones, with a ...

This article first appeared on GuruFocus. Vir Biotechnology Inc (NASDAQ:VIR) is set to release its Q4 2025 earnings on Feb 23, 2026. The consensus estimate for Q4 2025 revenue is $23.18 million, and ...

HALIFAX COUNTY, Va. (WDBJ) - A core piece of history is growing at the Virginia International Raceway. Many people don’t tend to think about trees when they’re at a racetrack, but for VIR fans, that’s ...

GSK is walking away from a core piece of its $345 million bet on Vir Biotechnology. The partners have ended their collaboration on anti-influenza antibodies, freeing Vir to “actively” pitch the ...

Despite interest from GSK and high hopes of leading the next generation of influenza A prophylaxis, Vir Biotechnology’s monoclonal antibody has failed its first phase 2 challenge. The PENINSULA study ...

Vir Das won over the internet on Sunday with a heartwarming gesture for his fan, who waited for two years to watch him perform live. The actor-comedian shared a screenshot on his Instagram feed on ...

Vir Das is collaborating with the streaming giant Netflix for the fifth time. On Wednesday, the comedian and Netflix jointly announced their new venture. This marks his fifth project after the ...

UKRAINE - 2022/01/23: In this photo illustration, a Vir Biotechnology logo is seen on a smartphone and a computer screen. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images) ...

On Wednesday, Vir Biotechnology, Inc. (NASDAQ:VIR) stock traded higher after the company presented initial Phase 1 data from two of its dual-masked T-cell engagers (TCEs): VIR-5818, which targets a ...